Evaluating the Human Papillomavirus Self-Collection Experience in Individuals Who Have Experienced Sexual Trauma

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

16 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-09-06

Study Completion Date

2023-05-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study explores the human papillomavirus (HPV) self-collection experience among individuals with a history of sexual trauma. Cervical cancer is the fourth most common cancer in women worldwide and is the second leading cause of cancer-related death in women ages 29-39. Despite programs to improve accessibility of cervical cancer screening and overall high screening rates, disparities in routine surveillance have been demonstrated in certain populations, such as victims of intimate partner violence and sexual trauma. One barrier to participating in cervical cancer screening for this population is the office-based visit which necessitates the individual to undress, sit with their legs in stirrups, and undergo speculum examination for specimen collection. This type of visit may cause distress for participants who have experienced sexual violence. HPV self-collection has been studied with favorable outcomes in effectiveness and ease of use. This study evaluates the experience of HPV self-collection among individuals who have experienced sexual trauma.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Telehealth & HPV Self-Collection

NCT05089825

Gynecologic Cancer

COMPLETED NA

Effect of Human Papillomavirus Self-Collection on Cervical Cancer Screening in High Risk Women: My Body, My Test 3

NCT02651883

Cervical Cancer Uterine Cervical Neoplasms Human Papillomavirus

COMPLETED NA

Self-Sampling in Women Who Do Not Undergo Routine Cervical Screening

NCT00977392

Health Status Unknown Precancerous Condition

COMPLETED

Self-sampling and Human Papillomavirus (HPV)-Testing for Unscreened Women in Cervical Cancer Prevention

NCT01588301

Cervical Cancer Human Papillomavirus Infection

COMPLETED EARLY_PHASE1

The Selfie Study- Assessing Novel Markers for Cervical Cancer Screening From Self-collected Samples

NCT04423679

Human Papilloma Virus Cervical Cancer CIN 2/3

UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

PRIMARY OBJECTIVE:

I. To explore the HPV self-collection experience among individuals with a history of sexual trauma.

OUTLINE:

Participants complete a survey, use an HPV self-collection kit, and attend an interview over 30 minutes.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cervical Carcinoma Human Papillomavirus Infection

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Observational (survey, HPV self-collection, interview)

Participants complete a survey, use an HPV self-collection kit, and attend an interview over 30 minutes.

HPV Self-Collection

Intervention Type PROCEDURE

Use HPV self-collection kit

Interview

Intervention Type OTHER

Attend interview

Survey Administration

Intervention Type OTHER

Complete surveys

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

HPV Self-Collection

Use HPV self-collection kit

Intervention Type PROCEDURE

Interview

Attend interview

Intervention Type OTHER

Survey Administration

Complete surveys

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

At-home HPV Self Collection HPV Self Collection Human Papillomavirus Self-Collection

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Individuals with a cervix who are eligible for primary HPV testing (age 25 and older) according to national cervical cancer screening guidelines
* Identify themselves as having a history of IPV, sexual abuse, or sexual trauma
* Participants will also need to have access to a smartphone, tablet, or computer with video capability
* English speaking
* Reside in the State of Oregon
* Patients who have participated in prior HPV self-collection study (reference Institutional Review Board \[IRB\] number- IRB# 23478) will also be eligible to participate in the interview if they meet the remaining eligibility requirements (i.e. history of IPV, sexual abuse, sexual trauma)

Exclusion Criteria

* Individuals who are not English speaking
* Individuals \< 25 years old or no longer eligible/recommended to undergo cervical cancer screening
* Resides outside the state of Oregon
* Adults who are unable to consent or are decisionally impaired
* Individuals without a cervix (i.e. prior hysterectomy)

Minimum Eligible Age

25 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes